Westwood Holdings Group Inc. Sells 1,888 Shares of Amdocs Limited $DOX

Westwood Holdings Group Inc. reduced its position in shares of Amdocs Limited (NASDAQ:DOX) by 0.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 227,561 shares of the technology company’s stock after selling 1,888 shares during the period. Westwood Holdings Group Inc. owned about 0.20% of Amdocs worth $20,763,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in DOX. Dakota Wealth Management acquired a new stake in shares of Amdocs in the 2nd quarter valued at about $458,000. Foster & Motley Inc. boosted its holdings in Amdocs by 21.0% in the second quarter. Foster & Motley Inc. now owns 45,764 shares of the technology company’s stock worth $4,176,000 after acquiring an additional 7,934 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in Amdocs by 15.6% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,555 shares of the technology company’s stock valued at $963,000 after acquiring an additional 1,421 shares during the period. Acadian Asset Management LLC increased its holdings in shares of Amdocs by 36.2% during the second quarter. Acadian Asset Management LLC now owns 684,218 shares of the technology company’s stock valued at $62,416,000 after acquiring an additional 181,719 shares in the last quarter. Finally, Pzena Investment Management LLC raised its position in shares of Amdocs by 2.1% during the second quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company’s stock worth $597,719,000 after purchasing an additional 132,463 shares during the period. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Stock Performance

DOX stock opened at $77.74 on Friday. The business has a 50 day moving average of $83.02 and a 200-day moving average of $87.27. The firm has a market cap of $8.78 billion, a PE ratio of 15.77, a P/E/G ratio of 1.40 and a beta of 0.51. Amdocs Limited has a 12-month low of $75.35 and a 12-month high of $95.41. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.15 billion. During the same quarter in the prior year, the company earned $1.70 EPS. The business’s revenue for the quarter was down 9.0% on a year-over-year basis. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. As a group, sell-side analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date is Wednesday, December 31st. Amdocs’s dividend payout ratio (DPR) is 41.58%.

Analysts Set New Price Targets

Several research firms have weighed in on DOX. Stifel Nicolaus lowered their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a report on Wednesday. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a report on Thursday. Finally, Bank of America lowered their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, Amdocs currently has an average rating of “Moderate Buy” and an average price target of $97.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.